Quantitation of inflammatory responses to bacteria in young cystic fibrosis and control patients

American Journal of Respiratory and Critical Care Medicine

Volumn 160, Issue 1, 1999, Pages 186-191

  Muhlebach, Marianne S ^a,b   Stewart, Paul W ^a   Leigh, Margaret W ^a   Noah, Terry L ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b CB #7220 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 8;

ARTICLE; BACTERIAL COUNT; BACTERIAL INFECTION; BACTERIUM CULTURE; BRONCHOSCOPY; CHILD; CONTROLLED STUDY; CYSTIC FIBROSIS; CYTOKINE RELEASE; DISEASE ASSOCIATION; HUMAN; INFLAMMATION; LEUKOCYTE DIFFERENTIAL COUNT; LUNG LAVAGE; MAJOR CLINICAL STUDY; NEUTROPHIL; PATHOGENESIS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

EID: 0032770489     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.160.1.9808096     Document Type: Article

References (22)

1. Konstan, M. W., K. A. Hilliard, T. M. Norvell, and M. Berger. 1994. Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggests ongoing infection and inflammation. Am. J. Respir. Crit. Care Med. 150:448-454.
2. Khan, T. Z., J. S. Wagener, T. Bost, J. Martinez, F. J. Accurso, and D. W. H. Riches. 1995. Early pulmonary inflammation in infants with cystic fibrosis. Am. J. Respir. Crit. Care Med. 151:1075-1082.
3. Balough, K., M. McCubbin, M. Weinberger, W. Smits, R. Ahrens, and R. Fick. 1995. The relationship between infection and inflammation in the early stages of lung disease from cystic fibrosis. Pediatr. Pulmonol. 20:63-70.
4. Cantin, A. 1995. Cystic fibrosis lung inflammation: early, sustained, and severe. Am. J. Respir. Crit. Care Med. 151:939-941.
5. Noah, T. L., H. R. Black, P.-W. Cheng, R. E. Wood, and M. W. Leigh. 1997. Nasal and bronchoalveolar lavage fluid cytokines in early cystic fibrosis. J. Infect. Dis. 175:638-647.
6. Gilligan, P. H., P. A. Gage, D. F. Welch, M. J. Muszynski, and K. R. Wait. 1987. Prevalence of thymidine-dependent Staphylococcus aureus in patients with cystic fibrosis. J. Clin. Microbiol. 25:1258-1261.
7. Gilligan, P. H., P. A. Gage, L. M. Bradshaw, D. V. Schidlow, and B. T. DeCicco. 1985. Isolation medium for the recovery of Pseudomonas cepacia from respiratory secretions of patients with cystic fibrosis. J. Clin. Microbiol. 22:5-8.
8. Zar, J. H. 1984. Biostatistical Analysis, 2nd ed. Prentice-Hall, Inc., Englewood Cliffs, NJ.
9. Thorpe, J. E., R. P. Baughman, P. T. Frame, T. A. Wesseler, and J. L. Staneck. 1987. Bronchoalveolar lavage for diagnosing acute bacterial pneumonia. J. Infect. Dis. 155:855-861.
10. Kahn, F. W., and J. M. Jones. 1987. Diagnosing bacterial respiratory infection by bronchoalveolar lavage. J. Infect. Dis. 155:862-869.
11. Barker, P. M., R. E. Wood, and P. H. Gilligan. 1997. Lung infection with Burkholderia gladioli in a child with cystic fibrosis: acute clinical and spirometric deterioration. Pediatr. Pulmonol. 23:123-125.
12. Hoiby, N., E. W. Flensborg, B. Beck, B. Friis, S. V. Jacobsen, and L. Jobsen. 1977. Pseudomonas aeruginosa infection in cystic fibrosis: diagnostic and prognostic significance of Pseudomonas aeruginosa precipitins determined by means of cross immunoelectrophoresis. Scand. J. Respir. Dis. 58:65-79.
13. Hudson, V. L., C. L. Wielenski, and W. E. Regelman. 1993. Prognostic implications or initial oropharyngeal bacterial flora in patients with cystic fibrosis diagnosed before the age of two years. J. Pediatr. 122:854-860.
14. Thomassen, M. J., C. A. Demko, and C. F. Doershuk. 1987. Cystic fibrosis: a review of pulmonary infections and interventions. Pediatr. Pulmonol. 3:334-351.
15. Zach, M. S. 1990. Lung disease in cystic fibrosis - an updated concept. Pediatr. Pulmunol. 8:188-202.
16. Eigen, H., B. J. Rosenstein, S. FitzSimmons, and D. V. Scidlow. 1995. A multicenter study of alternate-day prednisone therapy in patients with cystic fibrosis. J. Pediatr. 126:515-523.
17. Konstan, M. W., P. J. Byard, C. H. Hopple, and P. B. Davis. 1995. Effect of high-dose ibuprofen in patients with cystic fibrosis. N. Engl. J. Med. 332:848-854.
18. Oppenheimer, E. H., and J. R. Esterly. 1975. Pathology of cystic fibrosis: review of the literature and comparison with 146 autopsied cases. Perspect. Pediatr. Pathol. 2:241-278.
19. Armstrong, D. S., K. Grimwood, J. B. Carlin, R. Carzino, J. P. Gutierrez, J. Hull, A. Olinsky, E. M. Phelan, C. F. Robertson, and P. D. Phelan. 1997. Lower airway inflammation in infants and young children with cystic fibrosis. Am. J. Respir. Crit. Care Med. 156:1197-1204.
20. DiMango, E. H. J. Zar, R. Bryan, and A. Prince. 1995. Diverse Pseudomonas aeruginosa gene products stimulate respiratory epithelial cells to produce interleukin-8. J. Clin. Invest. 96:2204-2210.
21. Black, H. R., J. R. Yankaskas, L. G. Johnson, and T. L. Noah. 1998. Interleukin-8 production by cystic fibrosis nasal epithelial cells after tumor necrosis factor-α and respiratory syncytial virus stimulation. Am. J. Respir. Cell Mol. Biol. 19:210-215.
22. Bonfield, T. L., M. W. Konstan, P. Burfeind, J. R. Panuska, J. B. Hilliard, and M. Berger. 1995. Normal bronchial epithelial cells constitutively produce the antiinflammatory cytokine interleukin-10, which is downregulated in cystic fibrosis. Am. J. Respir. Cell Mol. Biol. 13:257-261.